4//SEC Filing
KHOSRAVI BEHZAD 4
Accession 0001179110-10-016992
CIK 0000203077other
Filed
Dec 5, 7:00 PM ET
Accepted
Dec 6, 4:10 PM ET
Size
8.9 KB
Accession
0001179110-10-016992
Insider Transaction Report
Form 4
KHOSRAVI BEHZAD
VP, Global Quality
Transactions
- Sale
Common Stock
2010-12-02$39.74/sh−10,800$429,192→ 34,202 total - Exercise/Conversion
Common Stock
2010-12-02$17.36/sh+10,800$187,488→ 45,002 total - Exercise/Conversion
Stock Option (Right to Buy)
2010-12-02−10,800→ 0 totalExercise: $17.36From: 2003-12-09Exp: 2010-12-09→ Common Stock (10,800 underlying)
Footnotes (3)
- [F1]Includes 662 shares acquired through the Company Employee Stock Purchase Plan as of 7/31/2010.
- [F2]The sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on October 27, 2009.
- [F3]The price in Column 4 is a weighted average. The price actually received ranged from $39.67 to $39.82. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
Documents
Issuer
ST JUDE MEDICAL INC
CIK 0000203077
Entity typeother
Related Parties
1- filerCIK 0001469271
Filing Metadata
- Form type
- 4
- Filed
- Dec 5, 7:00 PM ET
- Accepted
- Dec 6, 4:10 PM ET
- Size
- 8.9 KB